This Article Full Text Full Text (PDF) Other Versions of this Article: MCB.00849-06v1 26/20/7707    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Latysheva, N. Articles by Berditchevski, F. Search for Related Content PubMed PubMed Citation Articles by Latysheva, N. Articles by Berditchevski, F.

Syntenin-1 Is a New Component of Tetraspanin-Enriched Microdomains: Mechanisms and Consequences of the Interaction of Syntenin-1 with CD63

Cancer Research UK Institute for Cancer Studies,¹ School of Biosciences, The University of Birmingham, Edgbaston, Birmingham, United Kingdom²

Received 12 May 2006/ Returned for modification 13 June 2006/ Accepted 7 August 2006

Tetraspanins are clustered in specific microdomains (named tetraspanin-enriched microdomains, or TERM) in the plasma membrane and regulate the functions of associated transmembrane receptors, including integrins and receptor tyrosine kinases. We have identified syntenin-1, a PDZ domain-containing protein, as a new component of TERM and show that syntenin-1 specifically interacts with the tetraspanin CD63. Detailed biochemical and heteronuclear magnetic resonance spectroscopy (NMR) studies have demonstrated that the interaction is mediated by the C-terminal cytoplasmic region of the tetraspanin and the PDZ domains of syntenin-1. Upon interaction, NMR chemical shift perturbations were predominantly localized to residues around the binding pocket of PDZ1, indicating a specific mode of recognition of the cytoplasmic tail of CD63. In addition, the C terminus of syntenin-1 has a stabilizing role in the CD63-syntenin-1 association, as deletion of the last 17 amino acids abolished the interaction. The CD63-syntenin-1 complex is abundant on the plasma membrane, and the elevated expression of the wild-type syntenin-1 slows down constitutive internalization of the tetraspanin. Furthermore, internalization of CD63 was completely blocked in cells expressing a syntenin-1 mutant lacking the first 100 amino acids. Previous results have shown that CD63 is internalized via AP-2-dependent mechanisms. Hence, our data indicate that syntenin-1 can counteract the AP-2-dependent internalization and identify this tandem PDZ protein as a new regulator of endocytosis.

Published ahead of print on 14 August 2006.

^¶ These authors equally contributed to this work.

This article has been cited by other articles:

• Ruiz-Mateos, E., Pelchen-Matthews, A., Deneka, M., Marsh, M. (2008). CD63 Is Not Required for Production of Infectious Human Immunodeficiency Virus Type 1 in Human Macrophages. J. Virol. 82: 4751-4761 [Abstract] [Full Text]  
• Beekman, J. M., Coffer, P. J. (2008). The ins and outs of syntenin, a multifunctional intracellular adaptor protein. J. Cell Sci. 121: 1349-1355 [Abstract] [Full Text]  
• Lekishvili, T., Fromm, E., Mujoomdar, M., Berditchevski, F. (2008). The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility. J. Cell Sci. 121: 685-694 [Abstract] [Full Text]  
• Estrach, S., Legg, J., Watt, F. M. (2007). Syntenin mediates Delta1-induced cohesiveness of epidermal stem cells in culture. J. Cell Sci. 120: 2944-2952 [Abstract] [Full Text]  
• Boukerche, H., Su, Z.-z., Emdad, L., Sarkar, D., Fisher, P. B. (2007). mda-9/Syntenin Regulates the Metastatic Phenotype in Human Melanoma Cells by Activating Nuclear Factor-{kappa}B. Cancer Res. 67: 1812-1822 [Abstract] [Full Text]